• Are MPO-ANCA+ patients at higher risk for chronic lung disease like pulmonary fibrosis or chronic respiratory symptoms? • Should cardiovascular disease risk be managed differently in patients who are MPO-ANCA+? The gene discussed is MPO; the disease is cardiovascular disorder.